Drug Development in Argentina

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Drug Development in Argentina

Drug Development in Argentina – Clinical Trials in Latin America

Drug development is a crucial aspect of the healthcare industry, and Argentina has emerged as a key player in this field in Latin America.

In this blog post, we will explore the drug development landscape in Argentina, including its strengths, challenges, and potential for growth.

Argentina has a thriving pharmaceutical industry, with a market value of approximately $11.5 billion in 2020, according to the Argentine Chamber of the Pharmaceutical Industry (CILFA).

The industry is supported by a skilled workforce and advanced research infrastructure, as well as a strong regulatory framework that ensures the safety and efficacy of new drugs.

The drug development in Argentina typically begins with the discovery of new drug candidates, which involves screening large libraries of compounds to identify those with the desired therapeutic properties.

Once a potential drug candidate has been identified, it must undergo preclinical testing to ensure that it is safe and effective.

Preclinical testing involves testing the drug candidate in animal models to evaluate its pharmacokinetics, toxicity, and efficacy. This process can take several years and requires significant financial investment, as well as expertise in toxicology, pharmacology, and other areas of biomedical research.

Once a drug candidate has successfully completed preclinical testing, it must undergo clinical trials to evaluate its safety and efficacy in humans.

Clinical trials in Argentina are subject to strict regulatory oversight by the National Administration of Drugs, Food and Medical Technology (ANMAT), which is responsible for ensuring that clinical trials are conducted in accordance with ethical and scientific standards, and that the data generated by these trials are reliable and accurate.

Clinical trials in Argentina typically follow the same three-phase process as clinical trials in other countries. Phase 1 clinical trials are designed to evaluate the safety and pharmacokinetics of the drug candidate in a small group of healthy volunteers.

Phase 2 clinical trials are designed to evaluate the safety and efficacy of the drug candidate in a larger group of patients with the target disease. Finally, phase 3 clinical trials are designed to confirm the safety and efficacy of the drug candidate in a large group of patients and to compare it to existing treatments or placebo.

Drug Development in Argentina

Cohortias th CRO of LATAM

Drug Development in Argentina

Medical Research in Argentina

Once a drug candidate has successfully completed clinical trials, it must be submitted to ANMAT for regulatory approval. This process typically involves a thorough review of the clinical trial data, as well as a review of the manufacturing process and labeling information.

Regulatory approval in Argentina can be a complex and time-consuming process, as it requires compliance with a variety of national and international regulations and standards. However, once a drug has been approved by ANMAT, it can be marketed and sold in Argentina, providing patients with access to new treatments and therapies.

Argentina also has a growing pharmaceutical manufacturing industry, which produces a wide range of pharmaceutical products, including generic drugs and branded medications.

The industry is highly competitive and has attracted significant investment from multinational pharmaceutical companies, which have established manufacturing facilities in Argentina to take advantage of the country’s skilled workforce, favorable regulatory environment, and strategic location.

In addition to drug development and manufacturing, Argentina has a strong research infrastructure, which includes several leading academic and research institutions, as well as government agencies and non-profit organizations.

These organizations provide funding, training, and support for drug development and clinical research, as well as for the translation of research findings into clinical practice.

Despite its strengths, drug development in Argentina also faces several challenges. One major challenge is the need for greater investment in research and development, particularly in areas such as biotechnology and personalized medicine.

Another challenge is the need for greater collaboration and coordination among stakeholders in the drug development ecosystem, including researchers, pharmaceutical companies, regulators, and patients.

Addressing these challenges will be critical to further expanding the drug development industry in Argentina and improving healthcare outcomes in the country.

One potential area for growth is in the development of new treatments for neglected diseases, such as Chagas disease and dengue fever, which disproportionately affect low-income and marginalized populations in Argentina.

Drug Development in Argentina 

Cohortias the CRO of LATAM

Source: World Courier

Medical Research in Argentina

Drug Development in Argentina

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Drug Development in Argentina

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Drug Development in Argentina

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Drug Development in Argentina

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Drug Development in Argentina

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Drug Development in Argentina

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Drug Development in Argentina

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Drug Development in Argentina

The Cohortias Team

Drug Development in Argentina

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Drug Development in Argentina

Network & Partnerships